Dr. Rachna Shroff is seeking a “goldmine of information” in her quest to extend survival and improve quality of life for patients with cancers of the liver, gallbladder and pancreas.Continue reading
Author Archive: AZBio
Two Arizona companies partner to democratize access to healthcare
ReDirect Health and AdviNOW Medical announced today that they have created a strategic partnership to deliver affordable, high-quality primary care to low-and-middle income populations using artificial intelligence (AI), Augmented Reality (AR), automated patient engagement and data analytics to improve efficiency and outcomes.Continue reading
Protect Medical Innovation Act of 2019 Receives Strong Arizona Support
The Protect Medical Innovation Act of 2019 ( HR 2207 and S. 692) would permanently repeal the Medical Device Excise Tax. The 2.3% levy on U.S. medical device sales went into effect in 2013 but was only in place for two years before Congress put a moratorium in place. When that ended in January 2018, a second moratorium was enacted that’s due to expire at the end of this year. Continue reading
IBM, KPMG, Merck and Walmart to Collaborate as Part of FDA’s Program to Evaluate the Use of Blockchain to Protect Pharmaceutical Product Integrity
The FDA pilot program explores innovative and emerging approaches for the tracing and verification of prescription products
Updated Guidance for Arizona Individual Income Taxpayers
The Arizona Department of Revenue issued the following guidance for individual income taxpayers now that the Arizona legislature has determined the matter of conforming to the Internal Revenue Code (IRC).
UA College of Medicine – Phoenix Student Surprised with $25,000 Scholarship from the Arizona Lottery
Dario Alvarez plans a future as a pediatrician to serve underrepresented communities.Continue reading
Helios Scholars at TGen prepares students for success
One intern seeks physician-scientist career after participating in real-life biomedical research at TGenContinue reading
Aqualung Therapeutics Corporation Receives $1.7 Million National Institute of Health (NIH) Fastrack Award
AQUALUNG THERAPEUTICS CORPORATION receives a $1.7 MILLION National Institutes of Health (NIH) Fastrack award to develop a novel immune-based therapeutic anitibody for critically ill patients with acute lung injury.